Last reviewed · How we verify
NCT06850857
Multi-Institutional IMPACT Validation
trial testing IMPACT-G Module in Facial Injuries in 500 participants. Enrolling by invitation.
30 June 2026
Quick facts
| Lead sponsor | University of Tennessee |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 July 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- IMPACT-G Module
- IMPACT-N Module
- IMPACT-O Module
- IMPACT-J Module
- 15D Control Survey
Conditions studied
- Facial Injuries — all drugs for Facial Injuries →
- Mandible Fracture — all drugs for Mandible Fracture →
- Le Fort — all drugs for Le Fort →
- Zygomaticomaxillary Complex Fracture — all drugs for Zygomaticomaxillary Complex Fracture →
Sponsor
University of Tennessee
Who can join
18 and older, any sex, with Facial Injuries or Mandible Fracture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to validate a novel patient-reported outcome measure (PROM) for patients suffering maxillofacial trauma: The Integrated Modular Patient-Reported Outcome Assessment for Craniomaxillofacial Trauma (IMPACT). The primary question is: Are the IMPACT modules valid and reliable measures to study quality-of-life (QOL) in patients with maxillofacial trauma? Patients presenting for routine clinic follow-up for maxillofacial trauma will be invited to complete the IMPACT in addition to the 15 Dimension (15D) QOL survey as a control.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06850857
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Facial Injuries
Currently open trials in the same condition.
- NCT04057638 — Craniomaxillofacial and Upper Extremity Allotransplantation · NA · recruiting
Other University of Tennessee trials
Trials by the same sponsor.
- NCT07465432 — Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries · Phase 4 · recruiting
- NCT07225725 — Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC) · NA · not yet recruiting
- NCT07227519 — Effects of UPF Warning Labels on Social Media Among Teens and Young Adults · NA · not yet recruiting
- NCT06745180 — Making Healthy Habits Stick · NA · recruiting
- NCT06737393 — Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06850857 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tennessee
- Last refreshed: 18 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06850857.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing